MedPath

CLARITIN LIQUID CAPSULES

CLARITIN LIQUID CAPSULES

Approved
DIN Number

02404494

Drug Class

Human

Market Date

Jul 1, 2013

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02404494
AIG Number0120416001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R06AX13 LORATADINE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification04:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LORATADINEActive
Strength: 10 MG
Monograph: LORATADINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.